Intermittent fasting (IF) has moved from the margins of biohacking culture to the mainstream of dietary advice with remarkable speed. Time-restricted eating protocols — particularly the 16:8 model (16 hours of fasting, 8 hours of eating) — have been adopted by millions of people worldwide, supported by a combination of promising early research, compelling personal testimonials, and enthusiastic media coverage.

But as longer-term studies begin to report their findings, a more complex picture is emerging — one that challenges some of the simplistic narratives that have driven IF's popularity and raises important questions about who benefits, who doesn't, and why the distinction matters.

The Metabolic Mechanism

The theoretical basis for intermittent fasting is physiologically sound. During a fasted state, insulin levels drop, prompting the body to shift from glucose metabolism toward fat oxidation. After approximately 12 to 14 hours of fasting, the liver's glycogen stores become depleted, and the body begins producing ketone bodies — an alternative fuel source derived from fatty acids. This metabolic switching, researchers believe, is a key mechanism through which IF produces its beneficial effects.

Additionally, fasting activates a cellular maintenance process called autophagy — literally "self-eating" — in which damaged proteins and dysfunctional cellular components are broken down and recycled. Autophagy is widely regarded as a protective mechanism against ageing, cancer, and neurodegenerative disease, and it is significantly upregulated during periods of caloric restriction.

Short-Term Benefits: Largely Confirmed

The short-term metabolic benefits of intermittent fasting are relatively well-established. Multiple randomised controlled trials have demonstrated improvements in fasting insulin levels, insulin sensitivity, blood lipid profiles, and markers of systemic inflammation over periods of 8 to 12 weeks. Weight loss is consistent, though the magnitude is typically comparable to conventional caloric restriction when total caloric intake is matched — suggesting that the weight loss effect is driven primarily by reduced energy intake rather than by any unique metabolic advantage of the fasting window itself.

"In the short term, intermittent fasting works well for many people — not because fasting is metabolically magical, but because restricting the eating window is an effective strategy for reducing total caloric intake without requiring calorie counting."

— Dr. Satchidananda Panda, Professor, Salk Institute for Biological Studies

The Long-Term Complication: Hormonal Adaptation

Where the narrative becomes more complex is in the longer-term hormonal effects. A 2025 longitudinal study published in Cell Metabolism followed 1,800 participants practising 16:8 intermittent fasting over 18 months, with comprehensive hormonal panels collected at baseline, 6 months, 12 months, and 18 months.

The findings were striking. While metabolic markers remained improved throughout the study period, a significant subset of participants — approximately 35% — showed progressive disruptions in thyroid function (specifically, a decline in free T3 and an elevation in reverse T3), cortisol rhythm (with elevated evening cortisol and blunted morning peaks), and reproductive hormone levels.

The Cortisol Question

One of the most underappreciated aspects of intermittent fasting is its interaction with the stress hormone cortisol. Fasting is, from the body's perspective, a stressor. The metabolic switching that IF proponents celebrate is mediated in part by a rise in cortisol, which mobilises stored energy to fuel the fasted state.

For individuals with otherwise low stress loads, this cortisol elevation is well within the body's adaptive capacity. But for individuals already carrying significant psychological or physiological stress — which, given the realities of modern life, describes a substantial portion of the population — the additional cortisol burden can tip the balance toward chronic hypercortisolism. The consequences include disrupted sleep, increased visceral fat storage (paradoxically, the very outcome IF is supposed to prevent), suppressed thyroid function, and impaired immune response.

Who Benefits Most — and Who Should Be Cautious

The emerging evidence suggests that intermittent fasting is not a universal intervention. The individuals most likely to benefit are those with metabolic syndrome or insulin resistance, those who find eating window restriction a practical tool for reducing overall caloric intake, males (who appear to tolerate daily fasting with fewer hormonal consequences), and those with relatively low baseline stress levels.

Individuals who should approach IF with caution — or consider modified protocols — include pre-menopausal women (who may benefit from a modified 14:10 protocol or non-consecutive fasting days rather than daily 16:8), anyone with a history of disordered eating, individuals with thyroid conditions or adrenal dysfunction, those under significant chronic stress, and high-volume athletes whose caloric requirements may be difficult to meet within a restricted window.

A More Personalised Approach

The trajectory of IF research is following a pattern familiar in nutrition science: an intervention that initially appeared universally beneficial is revealing itself to be highly individual in its effects. This does not invalidate intermittent fasting — it contextualises it. For the right individual, under the right conditions, it remains a valuable metabolic tool. But the assumption that everyone should be fasting, that longer fasts are necessarily better, and that one protocol suits all populations is not supported by the evidence as it currently stands.

The most responsible approach is to treat IF as one option among many, to monitor not just weight but hormonal markers over time, and to be willing to modify or abandon the practice if the data suggests it is producing more harm than benefit. In nutrition, as in medicine, the dose and the context make the intervention — and individual variation is the rule, not the exception.

This article has been reviewed by the Wellness Research editorial board for scientific accuracy. It is intended for informational purposes and does not constitute medical advice.